Zongertinib (BI 1810631) is a human HER2-selective tyrosine kinase inhibitor that covalently binds to both wild-type and mutated HER2 receptors, including exon 20 insertion mutations, whilst sparing EGFR signaling. Zongertinib has antitumor activity.
Molecular Weight:
535.6
Purity:
99.0%
CAS Number:
[2728667-27-2]
Formula:
C29H29N9O2
Target:
EGFR/HER2
* VAT and and shipping costs not included. Errors and price changes excepted
